5-[6-(2-azabicyclo[2.1.1]hexan-2-yl)-10,10-dimethyl-11-oxa-1,5,8-triazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraen-4-yl]pyrimidin-2-amine;5-[4-(2-azabicyclo[2.1.1]hexan-2-yl)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-3-(difluoromethoxy)pyridin-2-amine;4-(3,3-difluoropyrrolidin-1-yl)-6,6-dimethyl-2-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-8,9-dihydropurino[8,9-c][1,4]oxazine;5-[4-(dimethylamino)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile

C82H86F4N28O5 — CID 160723564

IUPAC5-[6-(2-azabicyclo[2.1.1]hexan-2-yl)-10,10-dimethyl-11-oxa-1,5,8-triazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraen-4-yl]pyrimidin-2-amine;5-[4-(2-azabicyclo[2.1.1]hexan-2-yl)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-3-(difluoromethoxy)pyridin-2-amine;4-(3,3-difluoropyrrolidin-1-yl)-6,6-dimethyl-2-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-8,9-dihydropurino[8,9-c][1,4]oxazine;5-[4-(dimethylamino)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile
SMILESCC1(C)OCCn2c1nc1c(N3CC4CC3C4)nc(-c3cnc(N)nc3)cc12.CC1=CCc2ncc(-c3nc(N4CCC(F)(F)C4)c4nc5n(c4n3)CCOC5(C)C)cc21.CN(C)c1nc(-c2cnc3[nH]cc(C#N)c3c2)nc2c1nc1n2CCCOC1.Nc1ncc(-c2nc(N3CC4CC3C4)c3nc4n(c3n2)CCCOC4)cc1OC(F)F
InChIInChI=1S/C23H24F2N6O.C20H21F2N7O2.C20H23N7O.C19H18N8O/c1-13-4-5-16-15(13)10-14(11-26-16)18-28-19(30-7-6-23(24,25)12-30)17-20(29-18)31-8-9-32-22(2,3)21(31)27-17;21-20(22)31-13-6-11(7-24-16(13)23)17-26-18-15(25-14-9-30-3-1-2-28(14)18)19(27-17)29-8-10-4-12(29)5-10;1-20(2)18-25-16-15(26(18)3-4-28-20)7-14(12-8-22-19(21)23-9-12)24-17(16)27-10-11-5-13(27)6-11;1-26(2)18-15-19(27-4-3-5-28-10-14(27)23-15)25-16(24-18)11-6-13-12(7-20)9-22-17(13)21-8-11/h4,10-11H,5-9,12H2,1-3H3;6-7,10,12,20H,1-5,8-9H2,(H2,23,24);7-9,11,13H,3-6,10H2,1-2H3,(H2,21,22,23);6,8-9H,3-5,10H2,1-2H3,(H,21,22)
InChIKeyRTKLHMDNCDFHQM-UHFFFAOYSA-N
MW1619.77 g/mol
LogP11.11
Rot. Bonds10

About 5-[6-(2-azabicyclo[2.1.1]hexan-2-yl)-10,10-dimethyl-11-oxa-1,5,8-triazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraen-4-yl]pyrimidin-2-amine;5-[4-(2-azabicyclo[2.1.1]hexan-2-yl)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-3-(difluoromethoxy)pyridin-2-amine;4-(3,3-difluoropyrrolidin-1-yl)-6,6-dimethyl-2-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-8,9-dihydropurino[8,9-c][1,4]oxazine;5-[4-(dimethylamino)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile

5-[6-(2-azabicyclo[2.1.1]hexan-2-yl)-10,10-dimethyl-11-oxa-1,5,8-triazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraen-4-yl]pyrimidin-2-amine;5-[4-(2-azabicyclo[2.1.1]hexan-2-yl)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-3-(difluoromethoxy)pyridin-2-amine;4-(3,3-difluoropyrrolidin-1-yl)-6,6-dimethyl-2-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-8,9-dihydropurino[8,9-c][1,4]oxazine;5-[4-(dimethylamino)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile (PubChem CID 160723564) has the molecular formula C82H86F4N28O5 and a molecular weight of 1619.77 g/mol. Its IUPAC name is 5-[6-(2-azabicyclo[2.1.1]hexan-2-yl)-10,10-dimethyl-11-oxa-1,5,8-triazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraen-4-yl]pyrimidin-2-amine;5-[4-(2-azabicyclo[2.1.1]hexan-2-yl)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-3-(difluoromethoxy)pyridin-2-amine;4-(3,3-difluoropyrrolidin-1-yl)-6,6-dimethyl-2-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-8,9-dihydropurino[8,9-c][1,4]oxazine;5-[4-(dimethylamino)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile.

Molecular Properties

Compound Name5-[6-(2-azabicyclo[2.1.1]hexan-2-yl)-10,10-dimethyl-11-oxa-1,5,8-triazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraen-4-yl]pyrimidin-2-amine;5-[4-(2-azabicyclo[2.1.1]hexan-2-yl)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-3-(difluoromethoxy)pyridin-2-amine;4-(3,3-difluoropyrrolidin-1-yl)-6,6-dimethyl-2-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-8,9-dihydropurino[8,9-c][1,4]oxazine;5-[4-(dimethylamino)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile
PubChem CID160723564
Molecular FormulaC82H86F4N28O5
Molecular Weight1619.77 g/mol
Exact Mass1618.73
IUPAC Name5-[6-(2-azabicyclo[2.1.1]hexan-2-yl)-10,10-dimethyl-11-oxa-1,5,8-triazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraen-4-yl]pyrimidin-2-amine;5-[4-(2-azabicyclo[2.1.1]hexan-2-yl)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-3-(difluoromethoxy)pyridin-2-amine;4-(3,3-difluoropyrrolidin-1-yl)-6,6-dimethyl-2-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-8,9-dihydropurino[8,9-c][1,4]oxazine;5-[4-(dimethylamino)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile
SMILESCC1(C)OCCn2c1nc1c(N3CC4CC3C4)nc(-c3cnc(N)nc3)cc12.CC1=CCc2ncc(-c3nc(N4CCC(F)(F)C4)c4nc5n(c4n3)CCOC5(C)C)cc21.CN(C)c1nc(-c2cnc3[nH]cc(C#N)c3c2)nc2c1nc1n2CCCOC1.Nc1ncc(-c2nc(N3CC4CC3C4)c3nc4n(c3n2)CCCOC4)cc1OC(F)F
InChIInChI=1S/C23H24F2N6O.C20H21F2N7O2.C20H23N7O.C19H18N8O/c1-13-4-5-16-15(13)10-14(11-26-16)18-28-19(30-7-6-23(24,25)12-30)17-20(29-18)31-8-9-32-22(2,3)21(31)27-17;21-20(22)31-13-6-11(7-24-16(13)23)17-26-18-15(25-14-9-30-3-1-2-28(14)18)19(27-17)29-8-10-4-12(29)5-10;1-20(2)18-25-16-15(26(18)3-4-28-20)7-14(12-8-22-19(21)23-9-12)24-17(16)27-10-11-5-13(27)6-11;1-26(2)18-15-19(27-4-3-5-28-10-14(27)23-15)25-16(24-18)11-6-13-12(7-20)9-22-17(13)21-8-11/h4,10-11H,5-9,12H2,1-3H3;6-7,10,12,20H,1-5,8-9H2,(H2,23,24);7-9,11,13H,3-6,10H2,1-2H3,(H2,21,22,23);6,8-9H,3-5,10H2,1-2H3,(H,21,22)
InChIKeyRTKLHMDNCDFHQM-UHFFFAOYSA-N
XLogP11.11
TPSA376.69 Ų
H-Bond Donors3
H-Bond Acceptors32
Rotatable Bonds10
Heavy Atoms119
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001619.77
LogP ≤ 511.11
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1032

Analyze 5-[6-(2-azabicyclo[2.1.1]hexan-2-yl)-10,10-dimethyl-11-oxa-1,5,8-triazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraen-4-yl]pyrimidin-2-amine;5-[4-(2-azabicyclo[2.1.1]hexan-2-yl)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-3-(difluoromethoxy)pyridin-2-amine;4-(3,3-difluoropyrrolidin-1-yl)-6,6-dimethyl-2-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-8,9-dihydropurino[8,9-c][1,4]oxazine;5-[4-(dimethylamino)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-[6-(2-azabicyclo[2.1.1]hexan-2-yl)-10,10-dimethyl-11-oxa-1,5,8-triazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraen-4-yl]pyrimidin-2-amine;5-[4-(2-azabicyclo[2.1.1]hexan-2-yl)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-3-(difluoromethoxy)pyridin-2-amine;4-(3,3-difluoropyrrolidin-1-yl)-6,6-dimethyl-2-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-8,9-dihydropurino[8,9-c][1,4]oxazine;5-[4-(dimethylamino)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile?
The IUPAC name of 5-[6-(2-azabicyclo[2.1.1]hexan-2-yl)-10,10-dimethyl-11-oxa-1,5,8-triazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraen-4-yl]pyrimidin-2-amine;5-[4-(2-azabicyclo[2.1.1]hexan-2-yl)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-3-(difluoromethoxy)pyridin-2-amine;4-(3,3-difluoropyrrolidin-1-yl)-6,6-dimethyl-2-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-8,9-dihydropurino[8,9-c][1,4]oxazine;5-[4-(dimethylamino)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile (CID 160723564) is 5-[6-(2-azabicyclo[2.1.1]hexan-2-yl)-10,10-dimethyl-11-oxa-1,5,8-triazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraen-4-yl]pyrimidin-2-amine;5-[4-(2-azabicyclo[2.1.1]hexan-2-yl)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-3-(difluoromethoxy)pyridin-2-amine;4-(3,3-difluoropyrrolidin-1-yl)-6,6-dimethyl-2-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-8,9-dihydropurino[8,9-c][1,4]oxazine;5-[4-(dimethylamino)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile.
What is the SMILES notation for 5-[6-(2-azabicyclo[2.1.1]hexan-2-yl)-10,10-dimethyl-11-oxa-1,5,8-triazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraen-4-yl]pyrimidin-2-amine;5-[4-(2-azabicyclo[2.1.1]hexan-2-yl)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-3-(difluoromethoxy)pyridin-2-amine;4-(3,3-difluoropyrrolidin-1-yl)-6,6-dimethyl-2-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-8,9-dihydropurino[8,9-c][1,4]oxazine;5-[4-(dimethylamino)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile?
The canonical SMILES for 5-[6-(2-azabicyclo[2.1.1]hexan-2-yl)-10,10-dimethyl-11-oxa-1,5,8-triazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraen-4-yl]pyrimidin-2-amine;5-[4-(2-azabicyclo[2.1.1]hexan-2-yl)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-3-(difluoromethoxy)pyridin-2-amine;4-(3,3-difluoropyrrolidin-1-yl)-6,6-dimethyl-2-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-8,9-dihydropurino[8,9-c][1,4]oxazine;5-[4-(dimethylamino)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile is CC1(C)OCCn2c1nc1c(N3CC4CC3C4)nc(-c3cnc(N)nc3)cc12.CC1=CCc2ncc(-c3nc(N4CCC(F)(F)C4)c4nc5n(c4n3)CCOC5(C)C)cc21.CN(C)c1nc(-c2cnc3[nH]cc(C#N)c3c2)nc2c1nc1n2CCCOC1.Nc1ncc(-c2nc(N3CC4CC3C4)c3nc4n(c3n2)CCCOC4)cc1OC(F)F.
What is the InChIKey of 5-[6-(2-azabicyclo[2.1.1]hexan-2-yl)-10,10-dimethyl-11-oxa-1,5,8-triazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraen-4-yl]pyrimidin-2-amine;5-[4-(2-azabicyclo[2.1.1]hexan-2-yl)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-3-(difluoromethoxy)pyridin-2-amine;4-(3,3-difluoropyrrolidin-1-yl)-6,6-dimethyl-2-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-8,9-dihydropurino[8,9-c][1,4]oxazine;5-[4-(dimethylamino)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile?
The InChIKey is RTKLHMDNCDFHQM-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H24F2N6O.C20H21F2N7O2.C20H23N7O.C19H18N8O/c1-13-4-5-16-15(13)10-14(11-26-16)18-28-19(30-7-6-23(24,25)12-30)17-20(29-18)31-8-9-32-22(2,3)21(31)27-17;21-20(22)31-13-6-11(7-24-16(13)23)17-26-18-15(25-14-9-30-3-1-2-28(14)18)19(27-17)29-8-10-4-12(29)5-10;1-20(2)18-25-16-15(26(18)3-4-28-20)7-14(12-8-22-19(21)23-9-12)24-17(16)27-10-11-5-13(27)6-11;1-26(2)18-15-19(27-4-3-5-28-10-14(27)23-15)25-16(24-18)11-6-13-12(7-20)9-22-17(13)21-8-11/h4,10-11H,5-9,12H2,1-3H3;6-7,10,12,20H,1-5,8-9H2,(H2,23,24);7-9,11,13H,3-6,10H2,1-2H3,(H2,21,22,23);6,8-9H,3-5,10H2,1-2H3,(H,21,22).
What are the key properties of 5-[6-(2-azabicyclo[2.1.1]hexan-2-yl)-10,10-dimethyl-11-oxa-1,5,8-triazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraen-4-yl]pyrimidin-2-amine;5-[4-(2-azabicyclo[2.1.1]hexan-2-yl)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-3-(difluoromethoxy)pyridin-2-amine;4-(3,3-difluoropyrrolidin-1-yl)-6,6-dimethyl-2-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-8,9-dihydropurino[8,9-c][1,4]oxazine;5-[4-(dimethylamino)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile?
5-[6-(2-azabicyclo[2.1.1]hexan-2-yl)-10,10-dimethyl-11-oxa-1,5,8-triazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraen-4-yl]pyrimidin-2-amine;5-[4-(2-azabicyclo[2.1.1]hexan-2-yl)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-3-(difluoromethoxy)pyridin-2-amine;4-(3,3-difluoropyrrolidin-1-yl)-6,6-dimethyl-2-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-8,9-dihydropurino[8,9-c][1,4]oxazine;5-[4-(dimethylamino)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile has a molecular weight of 1619.77 g/mol, XLogP of 11.11, 10 rotatable bonds, 3 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[6-(2-azabicyclo[2.1.1]hexan-2-yl)-10,10-dimethyl-11-oxa-1,5,8-triazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraen-4-yl]pyrimidin-2-amine;5-[4-(2-azabicyclo[2.1.1]hexan-2-yl)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-3-(difluoromethoxy)pyridin-2-amine;4-(3,3-difluoropyrrolidin-1-yl)-6,6-dimethyl-2-(5-methyl-7H-cyclopenta[b]pyridin-3-yl)-8,9-dihydropurino[8,9-c][1,4]oxazine;5-[4-(dimethylamino)-6,8,9,10-tetrahydropurino[8,9-c][1,4]oxazepin-2-yl]-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile is sourced from PubChem (CID 160723564), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).